LAMP1 and neoplasm: The expression of CD107a is higher on CD56dimCD16−NK cells than CD56dimCD16bright-NK cells [139], supporting that CD107a is supposed to decrease alongside CD16 in CD56dim-NK cells after targeting tumour cells.